Pankaj Sonawane 个人学术档案

2022202320243 43 43

开放获取的出版物数量

0 篇文章

1 篇文章

可查看的文章

无法查看的文章

根据资助方的强制性开放获取政策

Amita VermaSam Higginbottom University of Agriculture, Technology and Sciences, Allahabad在 shiats.edu.in 的电子邮件经过验证
Prateek PathakGITAM University在 gitam.edu 的电子邮件经过验证
Maria GrishinaЮУрГУ, высшая медико-биологическая школа, лаборатория компьютерного моделирования лекарственных средств在 susu.ru 的电子邮件经过验证
Dr. Pradeep KumarAssistant Professor at Central University of Punjab, Ghudda, Bathinda, India - 151401在 cup.edu.in 的电子邮件经过验证
Jagat Pal YadavSam Higginbottom University of Agriculture, Technology and Sciences, Allahabad在 shiats.edu.in 的电子邮件经过验证
Habibullah Khalilullah, Ph D.Associate Professor, Unaizah College of Pharmacy, Qassim University在 qu.edu.sa 的电子邮件经过验证
Abdul-Hamid EmwasKAUST在 kaust.edu.sa 的电子邮件经过验证
Ankit K. SinghCentral university of Punjab, Bathinda在 cup.ac.in 的电子邮件经过验证

Pankaj Sonawane

Research Scholar at IISER Bhopal.

在 iiserb.ac.in 的电子邮件经过验证 - 首页


标题按引用次数排序按年份排序按标题排序	引用次数引用次数	年份
Concept of hybrid drugs and recent advancements in anticancer hybrids AK Singh, A Kumar, H Singh, P Sonawane, H Paliwal, S Thareja, ... Pharmaceuticals 15 (9), 1071, 2022	55	2022
Metal Complexes in cancer treatment: Journey so far A Kumar Singh, A Kumar, H Singh, P Sonawane, P Pathak, M Grishina, ... Chemistry & Biodiversity 20 (4), e202300061, 2023	22	2023
Challenges and Opportunities in the Crusade of BRAF Inhibitors: From 2002 to 2022 AK Singh, P Sonawane, A Kumar, H Singh, V Naumovich, P Pathak, ... ACS omega 8 (31), 27819-27844, 2023	7	2023
Concept of hybrid drugs and recent advancements in anticancer hybrids., 2022, 15, 1071 AK Singh, A Kumar, H Singh, P Sonawane, H Paliwal, S Thareja, ... DOI: https://doi. org/10.3390/ph15091071, 0	5
Applications of dihydropyrimidinone derivatives on blood cancer and colon cancer AK Singh, H Singh, P Sonawane, A Kumar, A Verma, P Kumar Dihydropyrimidinones as Potent Anticancer Agents, 173-198, 2023		2023

系统目前无法执行此操作，请稍后再试。

文章 1–5

每年引用数